Corbus Pharmaceuticals I... (CRBP)
NASDAQ: CRBP
· Real-Time Price · USD
9.86
-0.16 (-1.60%)
At close: Sep 05, 2025, 3:59 PM
9.72
-1.42%
After-hours: Sep 05, 2025, 07:42 PM EDT
-1.60% (1D)
| Bid | 9.6 |
| Market Cap | 120.84M |
| Revenue (ttm) | 703.38K |
| Net Income (ttm) | -57.95M |
| EPS (ttm) | -4.76 |
| PE Ratio (ttm) | -2.07 |
| Forward PE | -1.9 |
| Analyst | Buy |
| Ask | 10.2 |
| Volume | 56,795 |
| Avg. Volume (20D) | 146,496 |
| Open | 10.11 |
| Previous Close | 10.02 |
| Day's Range | 9.75 - 10.11 |
| 52-Week Range | 4.64 - 56.93 |
| Beta | 3.09 |
About CRBP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRBP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRBP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-15.77%
Corbus Pharmaceuticals Holdings shares are trading...
Unlock content with
Pro Subscription
1 month ago · fool.com
Corbus (CRBP) Q2 Loss Beats EstimatesCorbus (CRBP) Q2 Loss Beats Estimates
2 months ago · seekingalpha.com
Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data?CRBP's pipeline shows promise, especially CRB-701 with early signals of benefit and tolerability, but all programs remain in early clinical stages. The company's financial position is stable for now, ...